Insmed Incorporated

DB:IM8N Stock Report

Market Cap: €11.6b

Insmed Management

Management criteria checks 2/4

Insmed's CEO is Will Lewis, appointed in Sep 2012, has a tenure of 12.17 years. total yearly compensation is $10.41M, comprised of 7.5% salary and 92.5% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth €29.03M. The average tenure of the management team and the board of directors is 5 years and 10.5 years respectively.

Key information

Will Lewis

Chief executive officer

US$10.4m

Total compensation

CEO salary percentage7.5%
CEO tenure12.2yrs
CEO ownership0.3%
Management average tenure5yrs
Board average tenure10.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Will Lewis's remuneration changed compared to Insmed's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$864m

Jun 30 2024n/an/a

-US$803m

Mar 31 2024n/an/a

-US$747m

Dec 31 2023US$10mUS$780k

-US$750m

Sep 30 2023n/an/a

-US$724m

Jun 30 2023n/an/a

-US$696m

Mar 31 2023n/an/a

-US$547m

Dec 31 2022US$8mUS$735k

-US$482m

Sep 30 2022n/an/a

-US$434m

Jun 30 2022n/an/a

-US$416m

Mar 31 2022n/an/a

-US$438m

Dec 31 2021US$7mUS$710k

-US$435m

Sep 30 2021n/an/a

-US$424m

Jun 30 2021n/an/a

-US$375m

Mar 31 2021n/an/a

-US$319m

Dec 31 2020US$6mUS$660k

-US$294m

Sep 30 2020n/an/a

-US$245m

Jun 30 2020n/an/a

-US$242m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$7mUS$641k

-US$254m

Sep 30 2019n/an/a

-US$293m

Jun 30 2019n/an/a

-US$320m

Mar 31 2019n/an/a

-US$330m

Dec 31 2018US$6mUS$610k

-US$324m

Sep 30 2018n/an/a

-US$298m

Jun 30 2018n/an/a

-US$256m

Mar 31 2018n/an/a

-US$224m

Dec 31 2017US$4mUS$567k

-US$193m

Compensation vs Market: Will's total compensation ($USD10.41M) is above average for companies of similar size in the German market ($USD5.24M).

Compensation vs Earnings: Will's compensation has increased whilst the company is unprofitable.

CEO

Will Lewis (55 yo)

12.2yrs

Tenure

US$10,411,260

Compensation

Mr. William H. Lewis, also known as Will, J.D. M.B.A. serves as an Independent Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January 2024. He has been Chief Executive Officer and...

Leadership Team

NamePositionTenureCompensationOwnership
William Lewis
President12.2yrsUS$10.41m0.25%
€ 29.0m
Sara Bonstein
Chief Financial Officer4.8yrsUS$4.56m0.010%
€ 1.2m
Roger Adsett
Chief Operating Officer5yrsUS$4.01m0.036%
€ 4.1m
John Wise
Chief Commercial Officer5yrsUS$3.89m0.029%
€ 3.3m
Martina Flammer
Chief Medical Officer4.9yrsUS$4.22m0.0071%
€ 820.3k
Brian Kaspar
Chief Scientific Officerno datano datano data
Eleanor Barisser
Associate Director of Investor Relationsno datano datano data
Michael Smith
Chief Legal Officer & Corporate Secretary3.3yrsno data0.038%
€ 4.4m
Mandy Fahey
Executive Director of Corporate Communicationsno datano datano data
S. Schaeffer
Chief People Strategy Officer11.8yrsUS$2.66m0.019%
€ 2.2m
Eugene Sullivan
Chief Product Strategy Officer7.5yrsUS$1.69mno data
Neil Hughes
GM & Head of Europe5.4yrsno datano data

5.0yrs

Average Tenure

55yo

Average Age

Experienced Management: IM8N's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
William Lewis
President12.2yrsUS$10.41m0.25%
€ 29.0m
David W. McGirr
Independent Director11.1yrsUS$320.00k0.048%
€ 5.5m
Melvin Sharoky
Independent Director23.5yrsUS$312.50k0.18%
€ 21.0m
Alfred Altomari
Independent Director12.3yrsUS$320.00k0.031%
€ 3.6m
David Brennan
Lead Independent Director10.5yrsUS$345.00k0.061%
€ 7.0m
Clarissa Desjardins
Independent Director5yrsUS$315.00k0.027%
€ 3.2m
Elizabeth Anderson
Independent Director6yrsUS$310.00k0.031%
€ 3.6m
Leo Lee
Independent Director6.5yrsUS$317.50k0.062%
€ 7.2m
Carol Schafer
Independent Director4.6yrsUS$315.00k0.025%
€ 2.9m

10.5yrs

Average Tenure

65yo

Average Age

Experienced Board: IM8N's board of directors are seasoned and experienced ( 10.5 years average tenure).